Estrogen receptor-negative (ER-negative) endometrial carcinomas represent an emerging and historically underrecognized diagnostic concept encompassing a biologically aggressive and heterogeneous subset of endometrial cancers. The gene discussed is ESR1; the disease is endometrial cancer.